“…Increasing number of genetic variants are associated with various human diseases such as nephrocalcinosis (SLC26A1), hyperoxalemia (SLC26A1), diastrophic dysplasia (SLC26A2), achondrogenesis (SLC26A2), atelosteogenesis (SLC26A2), multiple epiphyseal dysplasia (SLC26A2), congenital chloride diarrhea (SLC26A3), deafness (SLC26A4 and SLC26A5), bicarbonate metabolism-related diseases (SLC26A6), hypothyroidism (SLC26A7), asthenozoospermia (SLC26A8), bronchiectasis (SLC26A9), and dysregulation of chloride homeostasis and neuroactivity (SLC26A11) (Alper and Sharma, 2013;Stenson et al, 2020). The amino acid sequences among the SLC26 family members are quite similar, and recent structural studies revealed that their overall molecular architectures are also similar for mammalian SLC26A4 , SLC26A5 (Bavi et al, 2021;Butan et al, 2022;Futamata et al, 2022;Ge et al, 2021), SLC26A6 (Tippett et al, 2023), and SLC26A9 (Chi et al, 2020;Walter et al, 2019). Thus, it is conceivable that a common molecular mechanism underlies their diverse physiological roles, and the pathogenic variants found in one SLC26 protein may affect the functions of the other family members in similar manners.…”